Total Clarity Wealth Management, Inc. Mereo Biopharma Group PLC Transaction History

Total Clarity Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$2.3 - $4.05 $27,277 - $48,033	11,860 New	11,860 $39,000
Q2 2022 Jul 29, 2022	BUY	$0.33 - $1.69 $660 - $3,380	2,000 New	2,000 $2,000
Q1 2022 Apr 29, 2022	SELL	$1.04 - $1.7 $2,080 - $3,400	-2,000 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$1.51 - $2.59 $566 - $971	-375 Reduced 15.79%	2,000 $3,000
Q3 2021 Oct 21, 2021	BUY	$2.2 - $3.17 $5,225 - $7,528	2,375 New	2,375 $6,000
Q2 2021 Jul 26, 2021	SELL	$2.94 - $4.08 $6,321 - $8,772	-2,150 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$2.6 - $4.43 $5,590 - $9,524	2,150 New	2,150 $7,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $440M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.